{"transactions":[{"id":4640516,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-14T21:19:51.000Z","date":"2026-10-12","kind":"sale","planned":false,"acquired":false,"shares":6335,"price":1.3606,"value":8619.401,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units (\"RSUs\") of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 7,707 restricted stock units."}],"balance_after":60475,"source":{"system":"sec-edgar","filing":"0001610717-26-000438","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000161071726000438/form4.xml","form_type":"4"}},{"id":881688,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-26T00:53:07.000Z","date":"2026-02-23","kind":"grant","planned":false,"acquired":true,"shares":316100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":316100,"derivative":{"exercise_price":1.07,"expiration_date":"2036-02-23","underlying":"Common Stock","underlying_shares":316100},"source":{"system":"sec-edgar","filing":"0001610717-26-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000161071726000071/form4.xml","form_type":"4"}},{"id":914231,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-09T21:07:00.000Z","date":"2026-02-06","kind":"sale","planned":false,"acquired":false,"shares":3826,"price":1.3071,"value":5000.9646,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units (\"RSUs\") of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,374 restricted stock units."}],"balance_after":66810,"source":{"system":"sec-edgar","filing":"0001610717-26-000046","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000161071726000046/form4.xml","form_type":"4"}},{"id":1018302,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-10-15T21:13:37.000Z","date":"2025-10-13","kind":"sale","planned":false,"acquired":false,"shares":6239,"price":2.505,"value":15628.695,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units (\"RSUs\") of the Issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 33,333 restricted stock units."}],"balance_after":70636,"source":{"system":"sec-edgar","filing":"0001610717-25-000362","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000161071725000362/form4.xml","form_type":"4"}},{"id":1111115,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:48:16.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000224","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000224/form4.xml","form_type":"4"}},{"id":1278544,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-08T01:17:12.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":161250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":161250,"derivative":{"exercise_price":4.37,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":161250},"source":{"system":"sec-edgar","filing":"0000905148-25-000440","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514825000440/form4.xml","form_type":"4"}},{"id":1278543,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-08T01:17:12.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":26875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 1/3rd of the shares on each annual anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":76875,"source":{"system":"sec-edgar","filing":"0000905148-25-000440","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514825000440/form4.xml","form_type":"4"}},{"id":1388046,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-10T22:20:24.000Z","date":"2024-10-10","kind":"grant","planned":false,"acquired":true,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of September 30, 2024, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":300000,"derivative":{"exercise_price":2.97,"expiration_date":"2034-10-10","underlying":"Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0000905148-24-002705","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514824002705/form4.xml","form_type":"4"}},{"id":1388045,"issuer":{"id":6428,"kind":"organization","name":"CODEXIS, INC.","symbol":"CDXS"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-10-10T22:20:24.000Z","date":"2024-10-10","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest as to 1/3rd of the shares on each annual anniversary of the grant date, subject to the Reporting Person's continued employment through the applicable vesting dates."}],"balance_after":50000,"source":{"system":"sec-edgar","filing":"0000905148-24-002705","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1200375/000090514824002705/form4.xml","form_type":"4"}},{"id":1489602,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:54:11.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":114000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/3rd of the total number of shares on the one year anniversary of June 4, 2024 and 1/36th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":114000,"derivative":{"exercise_price":1.78,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":114000},"source":{"system":"sec-edgar","filing":"0001610717-24-000293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000293/form4.xml","form_type":"4"}},{"id":1624817,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-22T22:02:44.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":54000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/36th of the total number of shares subject to the option in successive, equal monthly installments measured from February 20, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":54000,"derivative":{"exercise_price":2.59,"expiration_date":"2034-02-20","underlying":"Common Stock","underlying_shares":54000},"source":{"system":"sec-edgar","filing":"0001610717-24-000088","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000088/form4.xml","form_type":"4"}},{"id":2216957,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-07-01T16:25:41.000Z","date":"2022-07-01","kind":"disposition_to_issuer","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the terms of the merger agreement between issuer, GlaxoSmithKline plc (\"GSK\") and a subsidiary of GSK, this option was cancelled on the effective date of the merger in exchange for a cash payment equal to, on a per share basis, the offer price of $55.00 less the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest at the rate of 2.778% monthly, beginning on the one-month anniversary of the grant date, with 100% vested on the three-year anniversary of the grant date, subject to the provision of service by the Reporting Person to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"exercise_price":17.7575,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-22-040229","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919122040229/doc4.xml","form_type":"4"}},{"id":2418872,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-02-01T16:05:36.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total stock option will vest and become exercisable monthly on the same day of each month following the vesting commencement date of January 28, 2022, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":115000,"derivative":{"exercise_price":5.03,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001209191-22-005885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919122005885/doc4.xml","form_type":"4"}},{"id":2512330,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-15T16:02:19.000Z","date":"2021-11-11","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fifty percent of the stock option shall be fully vested and exercisable on the first anniversary of the vesting commencement date, November 11, 2022, and thereafter twenty-five percent of the stock option shall vest on each May 11, 2023, and November 11, 2023."}],"balance_after":115000,"derivative":{"exercise_price":7.73,"expiration_date":"2031-11-11","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001209191-21-064440","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919121064440/doc4.xml","form_type":"4"}},{"id":2561599,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-22T21:30:44.000Z","date":"2021-09-22","kind":"purchase","acquired":true,"shares":10300,"price":8.1,"value":83430.0,"ownership":{"direct":false,"nature":"By IRA"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares indirectly held by Georgia Leigh Erbez Charles Schwab & Co Inc Cust IRA Contributory (\"Georgia Erbez IRA Contributory\"). The Reporting Person has beneficial ownership over these shares held by Georgia Erbez IRA Contributory."}],"balance_after":19215,"source":{"system":"sec-edgar","filing":"0001209191-21-057342","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919121057342/doc4.xml","form_type":"4"}},{"id":2680745,"issuer":{"id":125698,"kind":"organization","name":"Sierra Oncology, Inc.","symbol":"SRRA"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T10:48:44.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest at the rate of 2.778% monthly, beginning on the one-month anniversary of the grant date, with 100% vested on the three-year anniversary of the grant date, subject to the provision of service by the Reporting Person to the Issuer on each vesting date."}],"balance_after":18000,"derivative":{"exercise_price":17.7575,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-21-038129","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1290149/000120919121038129/doc4.xml","form_type":"4"}},{"id":2848940,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-02-18T08:31:30.000Z","date":"2021-02-17","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 29, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":145908,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-011626","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919121011626/doc4.xml","form_type":"4"}},{"id":2848939,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-02-18T08:31:30.000Z","date":"2021-02-17","kind":"exercise","acquired":true,"shares":25000,"price":2.12,"value":53000.0,"ownership":{"direct":true},"balance_after":72292,"source":{"system":"sec-edgar","filing":"0001209191-21-011626","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919121011626/doc4.xml","form_type":"4"}},{"id":2889987,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-01-29T19:55:16.000Z","date":"2021-01-28","kind":"grant","acquired":true,"shares":72000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 1/48th of the shares subject to the option on February 28, 2021, and thereafter vests as to 1/48th of the shares in equal monthly installments at the end of each month, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":72000,"derivative":{"exercise_price":18.66,"expiration_date":"2031-01-27","underlying":"Common Stock","underlying_shares":72000},"source":{"system":"sec-edgar","filing":"0001209191-21-006304","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919121006304/doc4.xml","form_type":"4"}},{"id":3050733,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-20T18:36:55.000Z","date":"2020-08-19","kind":"purchase","acquired":true,"shares":5000,"price":11.4,"value":57000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares indirectly held by Georgia Leigh Erbez Charles Schwab & Co Inc Cust IRA Contributory (\"Georgia Erbez IRA Contributory\"). The Reporting Person has beneficial ownership over these shares held by Georgia Erbez IRA Contributory."}],"balance_after":8915,"source":{"system":"sec-edgar","filing":"0001209191-20-047804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919120047804/doc4.xml","form_type":"4"}},{"id":3050732,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-20T18:36:55.000Z","date":"2020-08-18","kind":"purchase","acquired":true,"shares":2098,"price":11.6,"value":24336.8,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares indirectly held by Georgia Leigh Erbez Charles Schwab & Co Inc Cust IRA Contributory (\"Georgia Erbez IRA Contributory\"). The Reporting Person has beneficial ownership over these shares held by Georgia Erbez IRA Contributory."}],"balance_after":3915,"source":{"system":"sec-edgar","filing":"0001209191-20-047804","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919120047804/doc4.xml","form_type":"4"}},{"id":3069064,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-08-04T08:32:22.000Z","date":"2020-07-31","kind":"purchase","acquired":true,"shares":1817,"price":10.92,"value":19841.64,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares indirectly held by Georgia Leigh Erbez Charles Schwab & Co Inc Cust IRA Contributory (\"Georgia Erbez IRA Contributory\"). The Reporting Person has beneficial ownership over these shares held by Georgia Erbez IRA Contributory."}],"balance_after":1817,"source":{"system":"sec-edgar","filing":"0001209191-20-044576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919120044576/doc4.xml","form_type":"4"}},{"id":3290623,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-02-04T20:09:04.000Z","date":"2020-01-31","kind":"grant","acquired":true,"shares":52160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 1/48th of the shares subject to the option on February 29, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments at the end of each month, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":52160,"derivative":{"exercise_price":13.29,"expiration_date":"2030-01-30","underlying":"Common Stock","underlying_shares":52160},"source":{"system":"sec-edgar","filing":"0001209191-20-006703","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919120006703/doc4.xml","form_type":"4"}},{"id":3303766,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-01-23T08:34:08.000Z","date":"2020-01-21","kind":"purchase","acquired":true,"shares":6700,"price":14.0922,"value":94417.74,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares indirectly held by David Milan Erbez Charles Schwab & Co Inc Cust IRA Contributory (\"Erbez IRA Contributory\").  The Reporting Person has beneficial ownership over these shares held by Erbez IRA Contributory."}],"balance_after":6700,"source":{"system":"sec-edgar","filing":"0001209191-20-004581","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919120004581/doc4.xml","form_type":"4"}},{"id":3349361,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2019-12-06T16:41:41.000Z","date":"2019-12-04","kind":"exercise","acquired":false,"shares":47292,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested and became exercisable as to 25% of the shares subject to the option on October 29, 2019, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":170908,"derivative":{"exercise_price":2.12,"expiration_date":"2028-11-16","underlying":"Common Stock","underlying_shares":47292},"source":{"system":"sec-edgar","filing":"0001209191-19-059489","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919119059489/doc4.xml","form_type":"4"}},{"id":3349360,"issuer":{"id":11424,"kind":"organization","name":"Harpoon Therapeutics, Inc.","symbol":"HARP"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-12-06T16:41:41.000Z","date":"2019-12-04","kind":"exercise","acquired":true,"shares":47292,"price":2.12,"value":100259.04,"ownership":{"direct":true},"balance_after":47292,"source":{"system":"sec-edgar","filing":"0001209191-19-059489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000120919119059489/doc4.xml","form_type":"4"}},{"id":4304290,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and Chief Business Officer"}}],"security":"Common Stock","published_at":"2017-05-25T20:55:10.000Z","date":"2017-05-25","kind":"purchase","acquired":true,"shares":68000,"price":1.32,"value":89760.0,"ownership":{"direct":true},"balance_after":115750,"source":{"system":"sec-edgar","filing":"0001587221-17-000018","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000158722117000018/edgar.xml","form_type":"4"}},{"id":4606538,"issuer":{"id":12518,"kind":"organization","name":"Zosano Pharma Corp","symbol":"ZSAN"},"owners":[{"id":64702,"kind":"person","name":"Erbez Georgia","position":1,"cik":"0001557930","reported_name":"Erbez Georgia","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CBO and Interim CFO"}}],"security":"Stock Option (right to buy)","published_at":"2016-09-09T16:29:18.000Z","date":"2016-09-07","kind":"grant","acquired":true,"shares":252000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option becomes exercisable on the first anniversary of the date of grant for 25% of the total number of option shares and becomes exercisable on the corresponding day of each month thereafter for an additional 1/48th of the total number of option shares, so that the stock option is fully vested on the fourth anniversary of the date of grant; provided, however, that 25% of the total option shares (in addition to any then-vested option shares) shall vest if the holder is terminated without cause or resigns for good reason (as these terms are defined in the holder's employment agreement); provided, further, that 100% of any then unvested option shares shall vest if the holder is terminated  without cause or resigns for good reason within one year after a change in control (as defined in the holder's employment agreement)."}],"balance_after":252000,"derivative":{"exercise_price":0.77,"expiration_date":"2026-09-07","underlying":"Common Stock","underlying_shares":252000},"source":{"system":"sec-edgar","filing":"0001557930-16-000010","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1557930/000155793016000010/edgar.xml","form_type":"4"}}]}